Skip to main content
. 2023 Feb 10;13:1099384. doi: 10.3389/fonc.2023.1099384

Figure 3.

Figure 3

Kaplan–Meier treatment-free survival curves with patients stratified according to neurofibromatosis type 2 status (A), extent of tumor removal (B), and optimal neutrophil-to-lymphocyte ratio cut-off value (C).